# 124: Fulfilling an Unmet Need - Live from IDWeek 2025! Page: https://stenobird.com/podcast/febrile-1336025/124-fulfilling-an-unmet-need-live-from-idweek-2025 Text version: https://stenobird.com/podcast/febrile-1336025/124-fulfilling-an-unmet-need-live-from-idweek-2025.md Podcast: [Febrile](https://stenobird.com/podcast/febrile-1336025) Published: 2025-11-03T06:00:00+00:00 Episode link: https://febrilepodcast.captivate.fm/episode/124-fulfilling-an-unmet-need-live-from-idweek-2025 Audio file: https://episodes.captivate.fm/episode/3383321f-ec92-4706-aa08-cbd9d3f1003e.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/febrile-1336025/episodes/124-fulfilling-an-unmet-need-live-from-idweek-2025 Duration seconds: 1580 ## Resource We are back and live from IDWeek 2025! Drs. Camille Kotton and Roy Chemaly join Febrile to discuss refractory HSV infection in immunocompromised patients! This episode was recorded at an IDWeek 2025 affiliated event in Atlanta, GA on October 20, 2025. Drs. Camille Kotton, Roy Chemaly, and Sara Dong were sponsored speakers by Aicuris Anti-infective Cures AG for this event, however this Febrile content was planned, produced, and reviewed solely by Febrile. Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com Febrile is produced with support from the Infectious Diseases Society of America (IDSA) ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/febrile-1336025/episodes/124-fulfilling-an-unmet-need-live-from-idweek-2025/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/febrile-1336025/124-fulfilling-an-unmet-need-live-from-idweek-2025.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.